HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Witte, D. L. Search for Related Content PubMed PubMed Citation Articles by Witte, D. L. Related Collections Molecular Diagnostics and Genetics Arnold O. Beckman Conference Evidence Based Laboratory Medicine and Test Utilization Hematology

Mild liver enzyme abnormalities: eliminating hemochromatosis as cause

^a Address for correspondence: Laboratory Control, Ltd., 1005 E. Pennsylvania, Ottumwa, IA 52501. Fax 515-682-8976.

Chronic mild liver enzyme abnormalities are attributable to hereditary hemochromatosis in at least 3% of cases. Hemochromatosis formerly was diagnosed late with diabetes and hepatic and cardiac failure. Only recently have the autosomal recessive inheritance and subtle early presentations been understood. However, patients still wait many years and see many physicians before receiving a correct diagnosis. Increased serum transferrin saturation is currently the best test for detection of those likely to accumulate iron. Serum ferritin identifies those requiring treatment. When liver biopsy (controversial in asymptomatic individuals) is indicated, chemical measurement of liver iron content is helpful and therapeutic phlebotomy is the only effective treatment. Caucasian-type hemochromatosis (prevalence of 0.005) is associated with genetic abnormalities in HLA-H but also occurs in other ethnic groups. Those of African descent may have a different but also heritable iron-loading disease. Caucasian-type and to a lesser extent African iron loading are detectable early by laboratory testing. Early treatment restores normal expectations of length and quality of life in the Caucasian disease. Long-term treatment data are not yet available in African iron loading. Laboratory-initiated screening programs using unsaturated iron-binding capacity can eliminate symptomatic hemochromatosis.

Key Words: indexing terms: iron metabolism • hemochromatosis • iron-binding capacity • ferritin • screening • HLA-H

The following articles in journals at HighWire Press have cited this article:

				E. Lyon and E. L. Frank Hereditary Hemochromatosis Since Discovery of the HFE Gene Clin. Chem., July 1, 2001; 47(7): 1147 - 1156. [Abstract] [Full Text] [PDF]

				D. R. Dufour, J. A. Lott, F. S. Nolte, D. R. Gretch, R. S. Koff, and L. B. Seeff Diagnosis and Monitoring of Hepatic Injury. II. Recommendations for Use of Laboratory Tests in Screening, Diagnosis, and Monitoring Clin. Chem., December 1, 2000; 46(12): 2050 - 2068. [Abstract] [Full Text] [PDF]

				P. C. Adams and V. Bhayana Unsaturated Iron-binding Capacity: A Screening Test for C282Y Hemochromatosis? Clin. Chem., November 1, 2000; 46(11): 1870 - 1871. [Full Text] [PDF]

				M Bhavnani, D Lloyd, A Bhattacharyya, J Marples, P Elton, and M Worwood Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase Gut, May 1, 2000; 46(5): 707 - 710. [Abstract] [Full Text] [PDF]

				E. R. Black Diagnostic strategies and test algorithms in liver disease Clin. Chem., August 1, 1997; 43(8): 1555 - 1560. [Abstract] [Full Text] [PDF]